ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637422 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637422; 2) Community: the network communities that were significantly associated with the response to NSC 637422; 3) Molecule: the relationships between components within communities and NSC 637422; 4) MDR: the compounds that were significantly associated with the NSC 637422.

NSC Compound Enrichment Correlation
NSC 655438 Null 0.0459335986102865 -0.16276762
NSC 690271 ANTINEOPLASTIC-690271 0.0459335986102865 -0.16412652
NSC 706190 6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- 0.0459335986102865 -0.18881198
NSC 718170 Null 0.0459335986102865 -0.07897561
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0459335986102865 -0.16702431
NSC 143925 Pekilocerin A 0.0459335986102869 0.13720116
NSC 625748 1,2,4,5-tetrazine, 3,6-bis(1-azetidinyl)- 0.0459335986102869 0.054515721
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.0459335986102872 -0.2385014
NSC 641177 Null 0.0459335986102872 -0.27901318
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.0459335986102872 -0.201057
Total:77  Current:68    [First] [Prev] [Next] [Last]